To The Moon

$Burning Rock Biotech Limited(BNR)$ is absolutely soaring! Watching it rise over tenfold—feels like hitting the lottery! All that research and patience finally paid off big time. The market rewards those who see true value!

$e.l.f. Beauty Inc.(ELF)$ This run on ELF has been strong! Solid earnings and fast growth, and once sentiment turned, the stock took off — watching those gains stack up feels great!

$CoreWeave, Inc.(CRWV)$ In the future landscape, $Oracle(ORCL)$ is in a prime offensive position thanks to its network architecture, while top Neoclouds like CoreWeave and $NEBIUS(NBIS)$ remain strong by securing long-term contracts with industry giants. Did everyone hold through this rally? Watching the gains climb has been such a satisfying feeling!

$T-Rex 2X Inverse NVDA Daily Target ETF(NVDQ)$ This run on NVDQ has been great — tech rotation with chips and AI leading the charge sent the stock climbing, and watching profits build up felt awesome, couldn’t be happier with the timing!

$NEBIUS(NBIS)$ The stock is clearly undervalued. ClickHouse announced a new round of financing, with the company’s valuation reaching $15 billion, and Nebius’ stake being revalued at $4.2 billion (up $2.7 billion from the previous round), which is undoubtedly a major positive. ClickHouse is a strategic asset, and its market value could reach $60–100 billion in the coming years… it’s a leader among similar products. Continuing to stay bullish.

$ProShares UltraPro Short QQQ(SQQQ)$ Riding SQQQ through the dip shows smart hedging in action. Watching profits grow while markets pull back feels strategic, not scared. Protecting capital is the real win.

$GraniteShares 2x Short NVDA Daily ETF(NVD)$ True strength always shows its timing! NVD’s breakout is like watching a champion reclaim the throne — chart soaring, portfolio hitting new highs. In the right trend, patience isn’t just a virtue, it’s a position. Legend continues.

$Novo-Nordisk A/S(NVO)$ surged 9.12% today on heavy volume, closing at $62.33, and continued to strengthen in after-hours trading. From a multi-timeframe technical perspective, it appears to be at the starting point of a new upward cycle — looks like a good entry opportunity, brothers.

$Burning Rock Biotech Limited(BNR)$ Holding BNR is such an emotional win! From being overlooked when its stock hit rock bottom to soaring 450% in a year and over 19% YTD, with its core product getting NMPA priority review and new tech showcased at international medical conferences, all this persistence finally paid off with solid profits.

$SUPER MICRO COMPUTER INC(SMCI)$ Who said the AI wave is over? Riding SMCI's server momentum feels like catching the tech tide at just the right time! Watching those numbers climb faster than my heartbeat — when you align with the trend, compute power truly delivers.

The U.S. Securities and Exchange Commission (SEC) has formally approved Nasdaq ISE's proposed rule change. Effective January 26, 2026, options on nine "mega-cap" company stocks and ETFs with top-tier market capitalization and liquidity will be added to the "Short Term Option Series (STO) Program," introducing new Monday and Wednesday short-term expiration dates. This move aims to provide traders with more flexible hedging and speculative tools while implementing stringent risk control requirements.Which 'Giants' Are Included in the New Program? (Q1 2026 List)According to the official Nasdaq list for Q1 2026, the following nine securities are the inaugural "Qualifying Securities":Tesla, Inc. (TSLA) $Tesla Motors(TSLA)$ NVIDIA Corporation (NVDA)

$PainReform(PRFX)$ PRFX Surged +37.96%: Biotech Stock Sees Explosive Volume, Tests $1.59 HighLatest Close Data: Closed at $1.13 on Jan 19, surging +37.96% on massive volume. This marks a significant move, now trading 83% below its 52-week high of $6.65.Core Market Drivers: The stock experienced extreme volatility with an intraday amplitude of 87.06%, indicating high speculative interest. No specific company news was cited in the provided data, suggesting the move may be driven by technical factors or broader biotech sector sentiment.Technical Analysis: The explosive move is confirmed by a colossal volume of 64.15M shares (Volume Ratio: 13.19x) and a sky-high 6-day RSI of 86.01, signaling severe overbought conditions. The MACD histogram turned posi

$e.l.f. Beauty Inc.(ELF)$ has been moving really clean.Solid fundamentals, money keeps flowing in, and the gains add up quietly.Didn’t overtrade, just held — and it paid off.

$ProShares Ultra Bloomberg Natural Gas(BOIL)$ So glad I held BOIL! Temperatures drop 20°F in key regions, gas demand jumps 1-2 Bcf/d, over $200M trading volume fuels strong rally – sweet gains!

$ImmunityBio, Inc.(IBRX)$ IBRX Soared +39.75%: Biotech Rocket Ignites, Touches 52-Week High at $5.58Latest Close Data: Closed at $5.52 on Jan 19, 2026, surging +39.75% and hitting its 52-week high.Core Market Drivers: Strong buying momentum fueled by a significant volume spike and potential short covering. The company's cancer immunotherapy pipeline, led by key asset Anktiva, continues to be a primary focus for investor optimism, despite the lack of specific new announcements today.Technical Analysis: Massive volume of 182M shares (Volume Ratio: 4.96) confirms the breakout. MACD (0.61) shows a strong bullish expansion, and RSI(6) at 98.8 indicates extreme overbought conditions, signaling a potential near-term pullback.Key Price Levels:Primary Supp

$CytomX Therapeutics(CTMX)$ CTMX Soared +26.82%: Biotech Surges to $5.39, Nears 52-Week HighLatest Close DataClosed at $5.39 on 2026-01-19, surging +26.82% with a massive 34.12% intraday amplitude. The price is just $0.31 shy of its 52-week high of $5.70.Core Market DriversThe stock experienced a significant breakout, likely fueled by strong capital inflow and positive sentiment in the biotech sector. High trading volume (13.4M shares, 5.88x volume ratio) and a 7.91% turnover rate indicate intense buying interest, potentially driven by anticipation of upcoming clinical data or partnership news.Technical AnalysisVolume surged to 13.4M shares, confirming the bullish breakout. The MACD (0.1206) has turned positive, signaling a strong momentum shift f

$NeoVolta, Inc.(NEOV)$ NEOV Skyrocketed +33.82%: High-Volume Breakout Towards $5, Consolidation LikelyLatest Close DataClosed at $4.59 (EST 01-20), surging +33.82% on massive volume. Price is now 25.8% below its 52-week high of $6.19.Core Market DriversThe stock experienced a powerful breakout, likely fueled by a combination of technical momentum and renewed speculative interest in the residential energy storage sector. The absence of recent company-specific news suggests this was a technically-driven move.Technical AnalysisVolume exploded to 5.37M shares (Volume Ratio: 10.73), confirming strong buying interest. The 6-day RSI at 73.5 indicates overbought conditions, signaling a potential near-term pullback. MACD (0.248) remains positive but the DI

$GE Vernova Inc.(GEV)$ GEV Rallies +6.12%: Clears Key Resistance, Eyes $760 TargetLatest Close DataClosed at $681.55 on 2026-01-19, up +6.12% (+$39.32). Currently sits just ~6.8% below its 52-week high of $731.00.Core Market DriversStrong institutional interest, as evidenced by significant capital inflows and top-tier shareholder base (Vanguard, BlackRock). Positive analyst sentiment reflects confidence in the energy transition play.Technical AnalysisVolume ratio of 1.95 signals strong buying interest. RSI(6) at 66.8 is approaching overbought territory, indicating strong short-term momentum. MACD remains negative but the DIF line is rising, suggesting bearish momentum is weakening.Key Price LevelsImmediate Pivot: $682.3 (Recent resistance, now test

$Moderna, Inc.(MRNA)$ MRNA Jumps +6.28%: Vaccine Leader Tests Key Resistance, Momentum BuildsLatest Close Data: Closed at $41.83 (Jan 19, 2026), up +6.28% on the day. This brings the stock within ~8% of its 52-week high of $45.40.Core Market Drivers: The surge appears driven by renewed positive sentiment in the biotech sector, possibly fueled by anticipation of new pipeline catalysts or seasonal flu/covid vaccine demand cycles. Continued high short interest (~18% of volume on Jan 16) may be contributing to short-term upward pressure.Technical Analysis: Volume was solid at 11.9M shares (volume ratio 0.83). The RSI(6) at 77.5 indicates strong short-term momentum but is nearing overbought territory. MACD remains bullish with DIF at 2.93 above DEA at

$Affirm Holdings, Inc.(AFRM)$ AFRM Rallies +4.11%: Bouncing from Key Support, Eyes $75.79 ResistanceLatest Close DataClosed at $74.76 (1/19/26), up +4.11% from prior close of $71.81. Currently sits -25.24% below its 52-week high of $100.00.Core Market DriversThe stock found footing above its recent support level, likely buoyed by continued investor optimism around its "Buy Now, Pay Later" (BNPL) model's resilience in the current consumer spending environment. Short interest remains elevated (24.15% as of 1/16), indicating a crowded bearish trade that could fuel further short-covering rallies.Technical AnalysisVolume was moderate at 5.62M shares (Vol Ratio 0.84). The RSI(6) jumped to 43.85, emerging from oversold territory (<30), signaling a shi